Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Studies from B.J. Loring and co-researchers in the area of immunization published
January 21st, 2009
Investigators publish new data in the report 'MeNZB vaccine and epidemic control: when do you stop vaccinating.' According to a study from Tauranga, New Zealand, "New Zealand developed a strain-specific group B meningococcal vaccine to control an epidemic. Following a mass vaccination campaign of three doses to the population under 20 years of age, commencing in July 2004, the vaccine continued to be offered routinely as a four-dose schedule from 6 weeks of age." "There is little international data on when to cease epidemic vaccination campaigns. The decision to stop using this vaccine needed to take into account a range of factors. These included epidemiology, vaccine...
Source: Vaccine Weekly (2009-01-21)
|
